Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Twist Bioscience Corporation is a diagnostics & research business based in the US. Twist Bioscience Corporation shares (TWST) are listed on the NASDAQ and all prices are listed in US Dollars. Twist Bioscience Corporation employs 525 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$114.49|
|52-week range||$74.25 - $214.07|
|50-day moving average||$111.30|
|200-day moving average||$114.70|
|Wall St. target price||$120.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.88|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||16.17%|
|1 month (2021-09-15)||1.36%|
|3 months (2021-07-15)||1.38%|
|6 months (2021-04-15)||-19.41%|
|1 year (2020-10-15)||14.62%|
|2 years (2019-10-15)||388.44%|
|3 years (2018-10-11)||N/A|
|5 years (2016-10-11)||N/A|
|Revenue TTM||$126.8 million|
|Gross profit TTM||$28.7 million|
|Return on assets TTM||-14.89%|
|Return on equity TTM||-28.18%|
|Market capitalisation||$4.9 billion|
TTM: trailing 12 months
There are currently 3.4 million Twist Bioscience Corporation shares held short by investors – that's known as Twist Bioscience Corporation's "short interest". This figure is 1.6% down from 3.4 million last month.
There are a few different ways that this level of interest in shorting Twist Bioscience Corporation shares can be evaluated.
Twist Bioscience Corporation's "short interest ratio" (SIR) is the quantity of Twist Bioscience Corporation shares currently shorted divided by the average quantity of Twist Bioscience Corporation shares traded daily (recently around 416253.89369592). Twist Bioscience Corporation's SIR currently stands at 8.09. In other words for every 100,000 Twist Bioscience Corporation shares traded daily on the market, roughly 8090 shares are currently held short.
However Twist Bioscience Corporation's short interest can also be evaluated against the total number of Twist Bioscience Corporation shares, or, against the total number of tradable Twist Bioscience Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Twist Bioscience Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Twist Bioscience Corporation shares in existence, roughly 70 shares are currently held short) or 0.0717% of the tradable shares (for every 100,000 tradable Twist Bioscience Corporation shares, roughly 72 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Twist Bioscience Corporation.
Find out more about how you can short Twist Bioscience Corporation stock.
We're not expecting Twist Bioscience Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Twist Bioscience Corporation's shares have ranged in value from as little as $74.25 up to $214.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Twist Bioscience Corporation's is 0.7463. This would suggest that Twist Bioscience Corporation's shares are less volatile than average (for this exchange).
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd. ; Victorian Clinical Genetic Services; Vivlion GmbH; CM Life Sciences II Inc. ; SomaLogic, Inc. ; Kyowa Kirin Pharmaceutical Research, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.